- ACGN Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-K/A Filing
Aceragen (ACGN) 10-K/A2012 FY Annual report (amended)
Filed: 30 Apr 13, 12:00am
Exhibit 31.3
CERTIFICATIONS
I, Sudhir Agrawal, certify that:
1. I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of Idera Pharmaceuticals, Inc.; and
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
/s/ SUDHIR AGRAWAL |
Sudhir Agrawal |
Chairman, President and Chief Executive Officer |
Date: April 30, 2013
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.